A. Octagon is a Delaware limited partnership formed on October 30, 2019, to operate as an investment adviser
with offices in New York, New York. Octagon is principally owned by Ting Jia. References to “us,” “we,” or
“our” in this Brochure refer to Octagon.
We provide discretionary investment advisory services to master-feeder, mini-master feeder, and Delaware
series trust structures comprised of affiliated pooled investment vehicles (each, a “Fund,” and collectively, the
“Funds”). We may in the future also provide investment advisory services to Separately Managed Accounts
(“SMAs,” collectively with the Funds, “Clients”). We generally seek to provide attractive risk-adjusted returns
by investing in healthcare companies with long-term compounding growth potentials on behalf of Clients.
Clients typically invest in securities and financial instruments of companies in the healthcare sector globally,
with focuses in companies headquartered in the United States, China, the European Union, and the United
Kingdom. Clients
may invest in securities on the open market, private placements, bonds, warrants, debt,
convertible debt, or securities, secondary or initial public offerings (“IPOs”); and/or other assets and financial
instruments.
B. We manage Client investments in accordance with investment objectives, strategies, guidelines, and terms
and conditions, as outlined in each Client’s applicable advisory agreement(s) or other governing document(s)
(collectively, “Governing Documents”). Octagon does not, however, provide individualized investment advice
or tailor its advisory services to the individual needs of any Fund’s underlying investors (“Investors”). Octagon
may enter into side letters with certain Investors, which could alter or supplement the terms of such Investor’s
investment.
C. We do not participate in wrap-fee programs.
D. As of December 31, 2023, we managed approximately $951,771,000 in regulatory assets under management
on a discretionary basis. We do not manage any non-discretionary assets.